Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,279 | -46,508 | N/A | -7,272 | -3,387 |
| Depreciation Amortization | 25,761 | 986 | N/A | 280 | 217 |
| Income taxes - deferred | -2,097 | -2,651 | N/A | N/A | N/A |
| Accounts receivable | 1,049 | 198 | N/A | 405 | 31 |
| Other Working Capital | 31,814 | 2,920 | N/A | -1,850 | -67 |
| Other Operating Activity | 4,458 | 8,142 | 0 | 727 | 369 |
| Operating Cash Flow | $-18,294 | $-36,913 | $N/A | $-7,710 | $-2,837 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -164,780 | 22,764 | N/A | N/A | N/A |
| PPE Investments | -54,079 | -1,072 | N/A | -266 | -380 |
| Net Acquisitions | N/A | 2,699 | N/A | N/A | N/A |
| Other Investing Activity | -72 | -18 | 0 | -18 | -30 |
| Investing Cash Flow | $-218,931 | $24,373 | $N/A | $-284 | $-410 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 289,433 | 918 | N/A | 56 | 64,693 |
| Dividend Paid | N/A | N/A | N/A | N/A | -9 |
| Other Financing Activity | -48 | -133 | 0 | 0 | 0 |
| Financing Cash Flow | $289,385 | $785 | $N/A | $56 | $64,684 |
| Beginning Cash Position | 9,420 | 21,175 | N/A | 64,010 | 2,573 |
| End Cash Position | 61,580 | 9,420 | N/A | 56,072 | 64,010 |
| Net Cash Flow | $52,160 | $-11,755 | $N/A | $-7,938 | $61,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,294 | -36,913 | N/A | -7,710 | -2,837 |
| Capital Expenditure | -54,414 | -1,072 | N/A | -266 | -381 |
| Free Cash Flow | -72,708 | -37,985 | 0 | -7,976 | -3,218 |